Tokyo, Nov. 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063506) titled 'Type two diabetes mellitus and heart failure with preserved ejection fraction treated with tirzepatide effects on exercise capacity' on Nov. 4.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Open -no one is blinded
Control - Active
Primary Sponsor:
Institute - St. Marianna University School of Medicine
Condition:
Condition - Type two diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To exploratorily evaluate the effects of tirzepatide, initiated as an approved treatment for type 2 diabetes mellitus, on...